Moonlake Immunotherapeutics (MLTX)
NASDAQ:MLTX
Want to see MLTX full AI Analyst Report?
MoonLake Immunotherapeutics (MLTX) Ownership Overview
13.55% Insiders
2.18% Mutual Funds
54.88% Other Institutional Investors
0.72% ETFs
28.67% Public Companies and
Individual Investors
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail, and individual investors. Approximately 57.79% of the company’s stock is owned by Institutional Investors, 13.55% is owned by Insiders, and 28.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 14, 2026 | xxxxxxxxxxxxx | $2752163 | |
Apr 02, 2026 | xxxxxxxxxxxxx | $62962500 | |
Dec 10, 2025 | xxxxxxxxxxxxx | $3012462 | |
Dec 10, 2025 | xxxxxxxxxxxxx | $2974700 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $393099 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,924,893 | Insider | 3.97% | 56,187,195 | |
| 2,859,940 | Insider | 3.88% | 54,939,447 | |
| 1,994,173 | Insider | 2.71% | 38,308,063 | |
| 1,154,555 | Insider | 1.57% | 22,179,002 | |
| 1,039,238 | Insider | 1.41% | 19,963,762 | |
| 887,029 | Institution | 1.20% | 17,039,827 | |
| 160,000 | Institution | 0.22% | 3,073,600 | |
| 143,558 | Institution | 0.20% | 2,757,749 | |
| 136,940 | Institution | 0.19% | 2,630,617 | |
| 129,145 | Institution | 0.18% | 2,480,875 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 887,029 | Institution | 1.20% | 17,039,827 | |
| 160,000 | Institution | 0.22% | 3,073,600 | |
| 143,558 | Institution | 0.20% | 2,757,749 | |
| 95,724 | Institution | 0.13% | 1,838,858 | |
| 75,847 | Institution | 0.10% | 1,457,021 | |
| 59,346 | Institution | 0.08% | 1,140,037 | |
| 41,878 | Institution | 0.06% | 804,476 | |
| 34,500 | Institution | 0.05% | 662,745 | |
| 29,143 | Institution | 0.04% | 559,837 | |
| 26,970 | Institution | 0.04% | 518,094 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 107,594 | Institution | 0.15% | 2,063,653 | |
| 80,185 | Institution | 0.11% | 1,540,354 | |
| 79,730 | Institution | 0.11% | 1,531,613 | |
| 56,771 | Institution | 0.08% | 1,090,571 | |
| 33,532 | Institution | 0.05% | 644,150 | |
| 30,913 | Institution | 0.04% | 593,839 | |
| 24,419 | Institution | 0.03% | 468,601 | |
| 16,858 | Institution | 0.02% | 323,505 | |
| 16,630 | Institution | 0.02% | 319,462 | |
| 9,751 | Institution | 0.01% | 187,122 |
FAQ
Who Owns Moonlake Immunotherapeutics (MLTX)?
According to the latest TipRanks data, approximately 54.88% of the company's stock is held by institutional investors, 13.55% is held by insiders, and 28.67% is held by retail investors.
What percentage of Moonlake Immunotherapeutics (MLTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.88% of Moonlake Immunotherapeutics (MLTX) stock is held by institutional investors.
What percentage of Moonlake Immunotherapeutics (MLTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 28.67% of Moonlake Immunotherapeutics (MLTX) stock is held by retail investors.
Who owns the most shares of Moonlake Immunotherapeutics (MLTX)?
Jorge Santos da Silva owns the most shares of Moonlake Immunotherapeutics (MLTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.